Comparison of the In Vitro Activity of the Glycylcycline Tigecycline (Formerly GAR-936) with Those of Tetracycline, Minocycline, and Doxycycline against Isolates of Nontuberculous Mycobacteria
- 1 October 2002
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 46 (10), 3164-7
- https://doi.org/10.1128/aac.46.10.3164-3167.2002
Abstract
Read the full review for this F1000Prime recommended article: Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria.Keywords
This publication has 24 references indexed in Scilit:
- Mycobacterium immunogenum sp. nov., a novel species related to Mycobacterium abscessus and associated with clinical disease, pseudo-outbreaks and contaminated metalworking fluids: an international cooperative study on mycobacterial taxonomy.International Journal of Systematic and Evolutionary Microbiology, 2001
- Mycobacterium wolinskyi sp. nov. and Mycobacterium goodii sp. nov., two new rapidly growing species related to Mycobacterium smegmatis and associated with human wound infections: a cooperative study from the International Working Group on Mycobacterial TaxonomyInternational Journal of Systematic and Evolutionary Microbiology, 1999
- Glycylcyclines: a new generation of tetracyclinesJournal of Antimicrobial Chemotherapy, 1995
- Tetracycline resistance determinants in Mycobacterium and Streptomyces speciesAntimicrobial Agents and Chemotherapy, 1994
- In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclinesAntimicrobial Agents and Chemotherapy, 1993
- Skin, Soft Tissue, and Bone Infections Due to Mycobacterium chelonae chelonae: Importance of Prior Corticosteroid Therapy, Frequency of Disseminated Infections, and Resistance to Oral Antimicrobials Other than ClarithromycinThe Journal of Infectious Diseases, 1992
- Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organismsAntimicrobial Agents and Chemotherapy, 1992
- Human Disease Due to Mycobacterium smegmatisThe Journal of Infectious Diseases, 1988
- Treatment of Nonpulmonary Infections Due to Mycobacterium fortuitum and Mycobacterium chelonei on the Basis of in Vitro SusceptibilitiesThe Journal of Infectious Diseases, 1985
- Clinical Usefulness of Amikacin and Doxycycline in the Treatment of Infection Due to Mycobacterium fortuitum and Mycobacterium cheloneiClinical Infectious Diseases, 1981